• No results found

18 results with keyword: 'cerebellar connectivity parkinson disease with levodopa induced dyskinesia'

Cerebellar Connectivity in Parkinson's Disease With Levodopa-Induced Dyskinesia

In a direct comparison of FC from the motor cerebellar seed between the PD-LID- and PD-LID + groups, the PD-LID + group had signifi- cantly increased FC between cerebellar lobule

Protected

N/A

10
0
0
2021
Parkinson Kinetic Graph: Are Motor Fluctuations in Parkinson Disease Related with Disease Duration?

Late Stage Parkinson Disease, Levodopa, Disease Duration, Fluctuations, Dyskinesia,

Protected

N/A

6
0
0
2020
HPC Software Debugger and Performance Tools

Knobloch SC Introduction, November 2015 13 DDT: Main Window Process controls Process groups Source code Variables Expression evaluator Stack trace... DDT:

Protected

N/A

80
0
0
2021
Levodopa-induced dyskinesia in Parkinson's disease: sleep matters

ADV = advanced fluctuating patients; AHI = apnea-hypopnea index; AIMS = abnormal involuntary movement scale; CTL = healthy control subjects; DNV = de novo patients; DYS =

Protected

N/A

35
0
0
2021
Parkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals

• Background: MJ Fox Foundation study to validate dyskinesia rating scales using amantadine; determine effect sizes for each scale to establish a bar against which new treatments

Protected

N/A

22
0
0
2021
Additional details >>> HERE

Video corso online di public speaking - un video corso online per imparare a parlare in pubblico - riccardo agostini life & public speaking coach - details corso online kick

Protected

N/A

5
0
0
2021
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

ADS-5102 provided reduction in motor complications in Parkinson’s disease patients with levodopa- induced dyskinesia switched from amantadine IR: subgroup analysis from

Protected

N/A

9
0
0
2020
Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease

The acute and chronic effects of administration of ranitidine at different doses (5 mg/kg, 10 mg/kg, and 20 mg/kg) on abnormal involuntary movements, levodopa-induced rotations,

Protected

N/A

8
0
0
2020
Clean Energy Options for Addressing High Electric Demand Days

At a minimum, energy efficiency programs promoting PC power management entail targeted outreach and education efforts. Programs can be education-only, informing customers about

Protected

N/A

73
0
0
2021
BALTIC 48 DP. Length of waterline. Volvo Penta MD11/ 135 hp. Year of construction 1986 The Netherlands. Balttic Yachts Finland Euro 245.

Hull and deck: Awl grip painted by Klaver Yachtpainting in 2011, new airvents stainless steel 2011.. Fin lead

Protected

N/A

11
0
0
2021
PRESCRIBING TRENDS IN PARKINSON’S DISEASE AND RISK FACTORS INVOLVED WITH LEVODOPA INDUCED MOTOR COMPLICATION IN A TERITIARY CARE HOSPITAL

parkinson disease and also highlight the known risk factors of levodopa induced

Protected

N/A

5
0
0
2020
Parkinson disease is a progressive

4,11 Monoamine oxidase-B inhibitors are less effective than either carbi- dopa/levodopa or dopamine agonists in treating motor symptoms of Parkinson disease, cause less dyskinesia

Protected

N/A

7
0
0
2021
KENMORE PARK INFANT & NURSERY SCHOOL

the Action plan/ engage the wider community in ECO projects / website is regularly updated Step 2 Environmental Review Conduct an environmental review with a group of ECO

Protected

N/A

6
0
0
2021
RFID BASED WAREHOUSE STRUCTURE DESIGNING USING EMULATOR

RFID in operation and supply chain. management by Thorsten

Protected

N/A

9
0
0
2020
Destructive Clustering of Metal Nanoparticles in Chalcogenide and Oxide Glassy Matrices

Different origin of high-order optical non-linearity asso- ciated with MNP embedded destructively in oxide- and chalcogenide glassy environment is evidenced from CCB

Protected

N/A

6
0
0
2020
Effect of Subthalamic Deep Brain Stimulation on Levodopa Induced Dyskinesia in Parkinson's Disease

Purpose: To evaluate the effect of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on levodopa-induced peak- dose dyskinesia in patients with Parkinson’s

Protected

N/A

6
0
0
2020
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease

Antonini A, Isaias IU, Rodolfi G et al (2011) A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep

Protected

N/A

5
0
0
2021
Double stratification effects on unsteady electrical MHD mixed convection flow of nanofluid with viscous dissipation and Joule heating

The aim of the current study is to investigate the combined effects of an electric field, magnetic field, thermal radiation, heat generation/absorption, chemical reaction,

Protected

N/A

13
0
0
2020

Upload more documents and download any material studies right away!